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THE DEVELOPMENT AND OPTIMIZATION OF A DIRECT LYSIS 
DIFFERENTIAL EXTRACTION METHOD 
MIKE N. YAKOO 
ABSTRACT 
With the publication of the first article on the forensic application of 
deoxyribonucleic acid (DNA) analysis, the authors demonstrated the ability to process 
samples acquired from victims of a sexual assault—samples, typically vaginal swabs, that 
oftentimes contain a mixture of sperm and epithelial cells (E-cells). The authors proposed 
a method that preferentially lyses E-cells while leaving sperm DNA, present in an ultra-
compact nucleoprotein complex specific to sperm, out of solution. This method, 
commonly referred to as the Gill method, has since been extensively used, relatively 
unmodified, in the processing of sexual assault samples. 
 While DNA extraction and analysis of forensic samples has improved 
significantly throughout the years, both in terms of process efficiency and the quality of 
results, the Gill method remains a labor intensive process. Additionally, most DNA 
extraction methods require purification of nucleic acids in order to perform downstream 
analyses, which inherently results in DNA loss. 
 Various methods have been developed that allow for the extraction of DNA 
without a subsequent purification step, often referred to as direct lysis methods. However, 
none have been shown to be viable options for use in sexual assault samples. ZyGEM 
(Hamilton, New Zealand) manufactures DNA extraction products containing the 
thermophilic EA1 protease, which has been shown to effectively digest DNA samples 
vi 
that are suitable for downstream processes, without the need for purification. We 
demonstrate the ability to utilize this protease, along with nuclease digestion of residual 
E-cell DNA (a process referred to as selective degradation), to produce a sperm sample 
with little to no E-cell DNA carryover, with only one centrifugation step. Subsequent 
sperm cell lysis is carried out with a second direct lysis product, Acrosolv (ZyGEM, 
Hamilton, New Zealand). The total processing time has been reduced to approximately 
two-and-a-half hours compared to over six hours with currently used extraction and 
purification methods.  
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1. Introduction 
Forensic deoxyribonucleic acid (DNA) analysis generally culminates with a 
comparison of two DNA profiles: one generated from the evidence and one from a 
known source, often referred to as a reference or standard. To produce a profile, DNA is 
amplified via the polymerase chain reaction (PCR) at multiple loci containing short 
tandem repeats (STRs) and the fluorescently labeled amplicons are subsequently 
separated by capillary electrophoresis (CE) to identify the allele sizes which correlate to 
the number of repeats at each locus. In an ideal situation, the evidence contains biological 
material from only one contributor and in a sufficient quantity to provide enough DNA to 
generate a complete profile. When the starting DNA is compromised, either by low mass 
amounts or degradation, the analysis becomes less straightforward. Additionally, when a 
sample contains DNA from multiple individuals, the convoluted resultant mixture adds a 
layer of complexity to analysis, oftentimes leading to inconclusive results. 
1.1. DNA Extractions 
Efficient cell lysis of a sample is needed to ensure all the DNA inside the cells is 
available for downstream analyses. The predominant method to extract evidence samples 
has essentially remained the same since forensic DNA analysis began: the stain is 
submerged in a solution containing sodium dodecyl sulfate (SDS) and Proteinase K (PK) 
and allowed to incubate for a certain length of time [1]. SDS, an anionic detergent, 
contributes both to cell lysis and protein denaturation while PK degrades cellular 
proteins. Proteolytic damage to histones helps release the DNA and damage to cellular or 
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environmental nucleases ensures the DNA that is released is not further degraded during 
the process [2]. 
1.2. DNA Purification Methods 
DNA purification methods are employed to analyze samples free of polymerase 
inhibitors, both environmental inhibitors and those, such as SDS, which may be added for 
cell lysis. Initial purification methods utilized organic solvents, most commonly phenol 
and chloroform, which have been used for decades to isolate nucleic acids [3–5]. 
However, because of their toxicity and the labor-intensive protocols associated with such 
extractions, the rise in the use of silica purifications ensued. The general concept of a 
silica purification is to extract the DNA in an acidic solution containing a chaotropic salt; 
this compound, typically guanidium thiocyanate or guanidium hydrochloride, disrupts the 
shell of hydration surrounding DNA by displacing the water molecules interacting with 
the phosphate backbone. As a result, when in contact with silica, the DNA, via 
hydrophobic interactions, will bind to the silica while most other components in solution 
will flow through. After a number of wash steps, the DNA can finally be eluted using 
water or a neutral or slightly basic buffer [6–9]. Various liquid-handling robotic 
instruments have been developed to automate the process which provide similar results to 
manual silica purifications [10]. 
While providing a product highly amenable to downstream processes, silica 
purification methods are associated with varying degrees of DNA loss. Failure for the 
DNA to adsorb onto silica, loss during wash steps and failure to desorb from silica are 
potential points of DNA loss. Additionally, there is a payoff between DNA binding 
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efficiency and its ability to effectively elute off of silica. At a lower pH, DNA has been 
shown to adsorb best onto silica; however, the ability to recover DNA becomes more 
compromised at this low pH [9,11]. In short, DNA loss using silica purification methods 
is unavoidable. 
1.3. Direct Cell Lysis Methods 
Various methods have been developed to lyse cells in a manner that is suitable for 
downstream processes without the need for purification. In doing so, the loss of DNA 
associated with purification methods is avoided; all of the starting DNA is present in the 
final sample along with the lysis reagents. Additionally, the time saved by foregoing 
purifications becomes substantial when multiple samples are being processed. The main 
drawback to these methods is that foreign inhibitors, such as dyes and humic acid, if 
present in a sample, are not removed prior to PCR-based analysis; as a result, samples 
extracted via direct lysis methods may fail to amplify if polymerase-inhibiting 
compounds are present [12]. 
One example of a direct lysis method is Chelex® 100, an amphoteric resin capable 
of chelating divalent cations under alkaline conditions. Because Mg2+ is a cofactor for 
nucleases, this chelating ability makes the material useful for DNA extractions. To lyse 
open cells and release DNA, the sample is boiled to rupture cellular and nuclear 
membranes and denature proteins. Carrying out the procedure under alkaline conditions 
deprotonates the iminodiacetic groups present in Chelex® 100, making them capable of 
binding to divalent ions in solution. The supernatant is then transferred, leaving Chelex® 
100 and the bound ions behind. As a result, some DNA is left behind in solution. Because 
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the extract is a crude lysate, cellular proteins, including nucleases which are inactivated 
due to the absence of cofactors, are still present in the sample. Additionally, because the 
sample was boiled, the DNA is single-stranded, making it less suitable for long-term 
storage. For these reasons, Chelex® 100, when used in a forensic laboratory, is used 
largely for reference samples [13]. 
1.4. Sexual Assault Samples 
Sexual assault samples, such as vaginal swabs, commonly contain a mixture of 2 
cell types: female epithelial cells and male sperm cells. Oftentimes the number of sperm 
cells collected is low, especially in relation to the number of epithelial cells, and because 
of this, when processing these samples without separating the sperm from the epithelial 
cells, a mixture will result that is predominantly from the female. The technique used to 
lyse these samples, termed a differential extraction, is a multi-step process that involves 
numerous incubation and centrifugation steps [14]. 
1.4.1. Differential Extractions 
With the publication of the first article on the forensic application of DNA 
analysis, the authors demonstrated the ability to process samples acquired from victims of 
a sexual assault. The proposed method preferentially lyses epithelial cells while leaving 
sperm DNA, present in an ultra-compact nucleoprotein complex specific to sperm, out of 
solution [1]. This method, commonly referred to as the Gill method, has since been 
extensively used, relatively unmodified, in the processing of sexual assault samples 
[14,15]. 
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The general concept of the Gill method is to extract the cell mixture in the 
presence of SDS and PK, lysing the non-sperm cells and releasing their DNA. While it is 
not entirely clear as to the extent of sperm lysis, which may relate to the conditions or age 
of sperm, it has been widely documented that sperm DNA remains largely out of 
solution, allowing for it to be centrifuged and pelleted [16]. The resulting supernatant, 
referred to as the non-sperm fraction (NSF), is removed and the sperm pellet is 
subsequently washed and re-pelleted, often several times, in order to ensure minimization 
of residual non-sperm DNA. The sperm pellet is finally digested with SDS and PK with 
the addition of a reducing agent, typically dithiothreitol (DTT), to reduce the disulfide 
bonds in the proteins that are tightly bound to the sperm DNA. In an ideal situation, the 
resulting sample will contain predominantly sperm DNA, ultimately leading to a male 
DNA profile [1]. 
1.4.2. Sperm Chromatin Structure 
During spermatogenesis, there is a complex and regulated process to go from 
diploid to haploid cells followed by repackaging DNA from histone-bound nucleosomes 
into an ultra-compact protein/DNA structure [17–19]. The majority of histones are 
replaced by two arginine-rich proteins, protamine 1 (P1) and protamine 2 (P2); P2 
undergoes post-translational modification and has two forms, P2a and P2b [20,21]. There 
was likely an evolutionary need to package sperm DNA into this form to prevent damage 
to DNA and ensure successful fertilization of an oocyte; abnormal P1/P2 or 
protamine/histone ratios in sperm is correlated with infertility in some men, indicating the 
importance of DNA compaction in sperm [22]. Because the protamine-DNA complex is 
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so compact, studies undertaken to learn more about its precise structure have yielded little 
information. While there is data to suggest there are inter- and/or intra-protamine 
disulfide bonds, their exact locations have yet to be determined [18,23–26]. The inability 
to isolate protamine without reducing these disulfide bonds is coincidentally the reason 
why separation of sperm from E-cells is possible. Because the DNA remains bound to 
these proteins, it will remain out of solution and able to be pelleted away from the 
epithelial DNA. PK cleavage of P1 and P2 (Figure 1) is limited enough to allow for 
differential extractions yet extensive enough that, under certain conditions, incubations 
can result in significant release of sperm DNA, even without the use of DTT [16]. 
 
Figure 1. PK cleavage sites to P1 (top) and P2 (bottom) as determined by UniProt’s ExPASy peptide cutter 
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           PK          PK                  PK                
         PK |         PK|              PK   |      PK        
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1.4.3. Selective Degradation with DNase I 
While it seems counterintuitive to introduce enzymes which degrade nucleic acids 
when conducting forensic DNA analysis, a method was developed to degrade residual E-
cell DNA in the sperm fraction using DNase I prior to extracting sperm DNA. The 
method has been shown to be effective while not damaging sperm DNA [27]. Because 
the sperm DNA is tightly bound by protamine, the nuclease is unable to damage sperm 
DNA while degrading residual female DNA in the sample, even following incubation 
with PK. Several labs, both in the United States and abroad, have validated and 
implemented similar protocols to process sexual assault evidence [15,28]. Wong et al., in 
a Department of Justice report, highlighted the process to optimize a selective 
degradation method for the Oakland Police Department in Oakland, California (CA). 
Experiments were carried out to optimize buffer compositions, including the detergent 
and nuclease cofactor concentrations used. It was found that inhibiting the nuclease with 
the addition of ethylenediaminetetraacetic acid (EDTA) was required prior to lysing 
sperm to prevent degradation of sperm DNA. The authors concluded that the method 
provided results similar to traditional differential extractions [28]. 
1.5. New Method Development 
The experiments highlighted in this document describe a direct lysis differential 
extraction method specific to E-cell/sperm mixtures that produces PCR-compatible non-
sperm and sperm fractions without the need for multiple centrifugation steps or 
subsequent DNA purifications.  
 
8 
1.5.1. EA1 Protease 
ZyGEM (Hamilton, New Zealand) manufactures a variety of direct lysis kits 
utilizing the thermophilic EA1 protease to digest samples and produce PCR-ready 
lysates. The use of a thermophile allows the enzyme to digest cellular proteins much 
more easily because while EA1 is active at higher temperatures, other peptides in the 
sample begin to denature, making them more amenable to hydrolysis [29]. Additionally, 
at 75 degrees Celsius (˚C), EA1’s optimal temperature, nucleases are inactive, allowing 
for the release of DNA and simultaneous degradation of nucleases, lowering the chance 
of nuclease attack on sample DNA. 
EA1 is a member of the thermolysin family of proteases; these enzymes have 
been shown to cleave peptides on the N-terminal side of leucine, valine, isoleucine, and 
phenylalanine [30]. There is no specific data describing the specificities for EA1; 
however, Saul et al. provide evidence that suggests EA1’s characteristics, aside from 
increased heat stability, are identical to other thermolysin proteases [31]. A study by 
Moss et al. comparing EA1 to Chelex® 100 indicated DNA yields were generally much 
higher with the EA1 protease across a range of samples typically encountered in forensic 
casework. Unlike PK which has trace levels of activity after being heat killed, EA1 has 
been shown to be completely inactive following incubation at 95˚C, making it suitable for 
PCR-based applications [31,32].  
The use of EA1 in sexual assault samples has been stifled by the inability to 
efficiently separate sperm from the DNA of ZyGEM-lysed E-cells. Preliminary work 
from this lab has indicated that ZyGEM extractions may fail to completely lyse cells [33]. 
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As a result, when sperm are lysed and analyzed, the final profile still contains a mixture 
of both sperm and E-cell DNA. When the ratio of E-cells to sperm cells is high, the male 
alleles may not be detected in such a sample. Additionally, EA1 is unable to release 
sperm DNA on its own; the minimal substrate specificity to protamine 1 and 2 (Figure 2) 
likely prohibits the dissociation of the protamine-DNA complex, even with the addition 
of DTT, requiring a new extraction method to lyse sperm once they are efficiently 
separated [32]. 
 
Figure 2. EA1 cleavage sites to P1 (top) and P2 (bottom) as determined by UniProt’s ExPASy peptide 
cutter based on thermolysin cleavage sites 
1.5.2. Acrosolv 
ZyGEM has recently developed forensicGEM™ Sex Crime, a direct lysis product 
for the extraction of sperm DNA. Because the EA1 protease is unable to release sperm 
DNA, the product utilizes a mesophilic protease that is capable of sperm cell lysis. This 
P1                                        EA1                
       EA1                               EA1|                
         |                                 ||                
         MARYRCCRSQSRSRYYRQRQRSRRRRRRSCQTRRRAMRCCRPRYRPRCRRH 
     1   ---------+---------+---------+---------+---------+-   51 
 
 
P2            EA1                                                     
           EA1  |                             EA1                     
       EA1   |  |         EA1            EA1    |                     
         |   |  |           |              |    |                     
         MVRYRVRSLSERSHEVYRQQLHGQEQGHHGQEEQGLSPEHVEVYERTHGQSHYRRRHCSR 
     1   ---------+---------+---------+---------+---------+---------+   60 
 
 
           EA1                                      
        EA1  |                                      
          |  |                                      
         RRLHRIHRRQHRSCRRRKRRSCRHRRRHRRGCRTRKRTCRRH 
    61   ---------+---------+---------+---------+--   102 
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protease is then digested by EA1 so that it does not inhibit downstream analyses by 
damaging Taq polymerase. Therefore, Acrosolv, similar to other ZyGEM products, does 
not require a purification step in order to be compatible with polymerases. 
1.5.3. Benzonase® 
 Benzonase® is an endonuclease from the gram-negative bacteria Serratia 
marescens and was chosen as a potential nuclease candidate for this new protocol 
because of its promiscuous nature; as opposed to DNase I which has a preference for 
double-stranded DNA, Benzonase® degrades all forms of DNA and ribonucleic acid 
(RNA), with no apparent partiality [34]. The ability to use a nuclease in this protocol is 
heightened by the presence of the EA1 protease at all times in solution, allowing for the 
digestion of the nuclease immediately following degradation of residual E-cell DNA by 
incubating the sample at 75˚C. Compared to other selective degradation methods, this 
method digests the nuclease rather than leaving it intact and inhibited by chelating 
nuclease cofactors with EDTA. Using the aforementioned characteristics for thermolysin 
and EA1 indicates that there are 81 cut sites to Benzonase® (Figure 3), demonstrating its 
ability to render the nuclease inactive and unable to degrade sperm DNA. Additionally, 
EA1 has significantly fewer cut sites to either protamine compared to PK, making 
nuclease damage of sperm DNA even less likely (Figures 1 and 2) than previously 
developed selective degradation differential extraction methods. 
 1 unit of the nuclease is described as the amount needed to completely digest 37 
µg of DNA in 30 minutes. The enzyme is active between 0˚C and 40˚C with an optimal 
temperature of 37˚C and little to no activity above 50˚C. While Ca2+ ions are not needed 
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for nuclease activity, Mg2+ is required, with an optimal concentration of 2 millimolar 
(mM) [35,36]. 
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Figure 3. EA1 cleavage sites to Benzonase® as determined by UniProt’s ExPasy PeptideCutter based on 
thermolysin cleavage sites 
                                     EA1                              
                                    EA1|                              
                                EA1   ||                              
                             EA1  |   ||                              
                          EA1  |  |   ||                              
                        EA1 |  |  |   ||                              
                      EA1 | |  |  |   ||                              
                     EA1| | |  |  |   ||                              
                    EA1|| | |  |  |   ||                              
                   EA1||| | |  |  |   ||                              
                  EA1|||| | |  |  |   ||                              
                 EA1||||| | |  |  |   ||                              
                EA1|||||| | |  |  |   ||                              
               EA1||||||| | |  |  |   ||                EA1           
              EA1|||||||| | |  |  |   ||             EA1  |           
             EA1||||||||| | |  |  |   ||          EA1  |  |           
            EA1|||||||||| | |  |  |   ||         EA1|  |  |      EA1  
        EA1   ||||||||||| | |  |  |   ||       EA1 ||  |  |     EA1|  
          |   ||||||||||| | |  |  |   ||         | ||  |  |       ||  
         MRFNNKMLALAALLFAAQASADTLESIDNCAVGCPTGGSSNVSIVRHAYTLNNNSTTKFA 
     1   ---------+---------+---------+---------+---------+---------+   60 
 
 
                                                   EA1                
                                                 EA1 |                
                                                EA1| |                
                                               EA1|| |                
                                             EA1 ||| |                
                                        EA1    | ||| |           EA1  
                                     EA1  |    | ||| |         EA1 |  
            EA1                   EA1  |  |    | ||| |        EA1| |  
         EA1  |                EA1  |  |  |    | ||| |      EA1 || |  
        EA1|  |   EA1         EA1|  |  |  |    | ||| |     EA1| || |  
          ||  |     |           ||  |  |  |    | ||| |       || || |  
         NWVAYHITKDTPASGKTRNWKTDPALNPADTLAPADYTGANAALKVDRGHQAPLASLAGV 
    61   ---------+---------+---------+---------+---------+---------+   120 
 
 
                                                       EA1            
                                                   EA1   |            
                                                EA1  |   |            
                 EA1          EA1      EA1    |  |   |                
              EA1  |        EA1 |   EA1  |    |  |   |                
           EA1  |  |        EA1 | |    EA1|  |    |  |   |            
             |  |  |          | | |      ||  |    |  |   |            
         SDWESLNYLSNITPQKSDLNQGAWARLEDQERKLIDRADISSVYTVTGPLYERDMGKLPG 
   121   ---------+---------+---------+---------+---------+---------+   180 
 
 
                                    EA1                               
                                   EA1|                               
                                  EA1||                               
                                 EA1|||                               
                                EA1||||                               
                            EA1   |||||                               
                           EA1|   |||||                               
                      EA1    ||   |||||                               
                     EA1|    ||   |||||              EA1          EA1 
                    EA1||    ||   |||||            EA1 |        EA1 | 
                   EA1|||    ||   |||||          EA1 | |       EA1| | 
         EA1   EA1   ||||    ||   |||||     EA1    | | |      EA1|| | 
           |     |   ||||    ||   |||||       |    | | |        ||| | 
         TQKAHTIPSAYWKVIFINNSPAVNHYAAFLFDQNTPKGADFCQFRVTVDEIEKRTGLIIW 
   181   ---------+---------+---------+---------+---------+---------+   240 
 
 
                EA1        EA1      
              EA1 |   EA1    |      
                | |     |    |      
         AGLPDDVQASLKSKPGVLPELMGCKN 
   241   ---------+---------+------   266 
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1.6. Hypothesis 
The enzymatic reagents EA1, Benzonase® and Acrosolv and their relative thermal 
profiles can be used to create an effective differential lysis protocol for cellular mixtures 
from sexual assault evidence. In theory this process could take less time and result in 
DNA which could go directly to amplification. 
2. Materials and Methods 
E-cell samples used for respective experiments were prepared by centrifuging 
fresh saliva samples from anonymous donors 2-3 times at 800 x g followed by removing 
the supernatant and resuspending the cells in 1x phosphate-buffered saline (PBS) 
(ThermoFisher, Waltham, MA). A semen sample purchased from BioreclamationIVT 
(Baltimore, MD) was stored at -20˚C upon receipt and each aliquot underwent only one 
freeze-thaw cycle. All dilutions were made with PBS. 
Benzonase® (Sigma-Aldrich, St. Louis, MO) dilutions were prepared using a 2x 
reaction buffer (40 mM Tris HCl, pH 8.0, 4 mM MgCl2, 40 mM NaCl) and the volume 
added was equivalent to sample volumes to achieve a 1x working solution. 
Quantifications were performed using Quantifiler® Duo (Applied Biosystems, 
Foster City, CA) in a 7500 Real-Time PCR instrument (Applied Biosystems, Foster City, 
CA) according to manufacturer’s specifications and DNA concentrations were 
determined using a previously calibrated standard curve [37]. Amplifications were 
conducted using AmplSTR® Identifiler® Plus (Applied Biosystems, Foster City, CA) in a 
GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA) 
according to manufacturer’s specifications and fragment separation was carried out using 
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an ABI 3130 Genetic Analyzer CE instrument (Applied Biosystems, Foster City, CA). 
Electropherograms (EPGs) were generated and analyzed using GeneMapper® ID-X 
version 1.1.1 (Applied Biosystems, Foster City, CA). 
2.1. Lysis Comparison of ZyGEM and QIAamp DNA Investigator Kits 
Because previous studies suggested the lysis efficiency of ZyGEM extractions 
was inferior to a SDS/PK method, further investigation of this claim was warranted prior 
to attempting to create a direct lysis differential extraction method using the EA1 
protease. In order to compare the two methods, ZyGEM extracts were purified using 
Qiagen spin columns to assess the loss of DNA associated with silica columns.  
Twenty microliters of an E-cell sample was digested using Qiagen’s QIAamp® 
DNA Investigator kit (QIAGEN, Hilden, Germany) containing PK and likely SDS (the 
exact formulation of Buffer ATL is not specified) according to manufacturer’s 
instructions for saliva samples, purified using the included silica column and eluted into 
100 µL of Buffer ATE (10 mM Tris pH 8.0, 1 mM EDTA, 0.04% NaN3) [38]. Forty 
microliters of the cell prep was also digested according to the ZyGEM forensicGEM™ 
Saliva (ZyGEM, Hamilton, New Zealand) protocol (138 µL H2O, 20 µL 10x Blue Buffer, 
2 µL forensicGEM™) in a 0.2 milliliter (mL) PCR tube using a SimpliAmp thermal 
cycler (Applied Biosystems, Foster City, CA) at a total volume of 200 µL; however, 100 
µL was removed prior to the 95˚C step because the DNA would have been single-
stranded making it unamenable to silica purification. The remaining 100 µL was 
subsequently incubated at 95˚C for 5 minutes. The ZyGEM portions that were not heated 
to 95˚C were then incubated at room temperature with 100 µL Buffer AL (the chaotropic 
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salt-containing solution provided with the Qiagen kit) for 10 minutes, purified according 
to the previously used Qiagen instructions and eluted into 100 µL Buffer ATE. Each 
extraction method was done in duplicate (n=2). The purified samples, as well as the 
unpurified ZyGEM extracts that were incubated at 95˚C were quantified. 
2.2. Differential Extraction with Benzonase®: First Protocol 
Equal volumes of 1:5 E-cell and 1:100 semen dilutions were mixed together to 
create a cell mixture. Forty microliters of the cell mixture was digested using 93 µL H2O, 
15 µL 10x Blue Buffer and 2 µL forensicGEM™ (total volume of 150 µL) in a 0.2 ml 
PCR tube. The samples were incubated at 75˚C for 15 minutes, 95˚C for 5 minutes then 
cooled down to 4˚C. The samples were subsequently centrifuged at 21,130 x g in a 
microcentrifuge for 5 minutes and 130 µL of the NSF was transferred to an appropriately 
labeled PCR tube. To the sperm pellet, .005 units of Benzonase® (.00025 units/µL, 20 
µL) was added; samples were vortexed and incubated at 37˚C for 30 minutes and 60˚C 
for 5 minutes. Thirty-seven microliters H2O, 10 µL 10x Orange Buffer, 10 µL Acrosolv 
and 2 µL forensicGEM™ were added to the samples and samples were incubated 
according to manufacturer’s instructions (52˚C for 5 minutes, 75˚C for 3 minutes, 95˚C 
for 3 minutes and cooled to 4˚C). An equal volume of the cell mixture was processed in a 
similar manner without the addition of Benzonase®; Benzonase® buffer was used instead.  
Twenty microliters of the E-cell prep was extracted with ZyGEM only and did not 
continue through the rest of the protocol. Two sets of sperm only samples were processed 
alongside the cell mixture throughout the full protocol except one set was not incubated 
with Benzonase®. A set of sperm samples was extracted with Acrosolv only in a total 
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volume of 100 µL. Extractions under each condition were carried out in triplicate. All 
incubations were conducted in a SimpliAmp thermal cycler. The samples were 
quantified, 1 nanogram (ng) of DNA was amplified, fragments were separated by CE and 
EPGs were generated. 
2.3. Benzonase® Optimization 
2.3.1. Benzonase® Concentration 
Ten microliters of previously quantified, Qiagen-purified DNA (approximately 
0.75 ng/µL based on replicate Quantifiler® Duo quantifications) was aliquoted into 0.2 
mL PCR tubes and digested with 250, 25, 2.50 or 0 units of Benzonase® in 10 µL (25, 
2.5, .25 or 0 units/µL, respectively) for 30 minutes at 37˚C. The reaction was stopped by 
the addition ZyGEM and subsequent digestion (6 µL H2O, 3 µL 10x Blue Buffer, 1 µL 
forensicGEM™) in a total volume of 30 µL. The samples were incubated at 75˚C for 15 
minutes, 95˚C for 5 minutes and 5˚C for 5 minutes. Digestion with each amount of 
Benzonase® was conducted twice. All incubations were conducted in a SimpliAmp 
thermal cycler and samples were subsequently quantified. 
2.3.2. Buffer Compatibility Tests 
In order to determine if the reaction buffer required for optimal Benzonase® 
activity has any effect on downstream PCR analyses, various combinations of reagents 
were tested with a purified DNA sample that had been quantified twice previously. In a 
0.2 ml PCR tube, 10 µL of purified DNA containing approximately 9 ng of DNA 
(previous duplicate concentrations of .880 and .943 ng/µL, respectively, determined by 
Quantifler® Duo) was added to 10 µL of either 2x buffer or H2O and incubated for 30 
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minutes at 37˚C (the time and temperature of a Benzonase® incubation) followed by 
either 24 µL H2O, 5 µL 10x Blue Buffer and 1 µL forensicGEM™ (30 µL total) or 30 µL 
H2O and incubated at 75˚C for 15 minutes, 95˚C for 5 minutes and 5˚C for 5 minutes (the 
time and temperature of a typical ZyGEM digest). All incubations were conducted in a 
SimpliAmp thermal cycler and samples were subsequently quantified. 
2.4. ZyGEM Degradation of Benzonase® 
In order to determine if the EA1 protease is capable of digesting and completely 
inactivating Benzonase® following degradation of the DNA in solution, 10 µL of DNA 
(approximately 1 ng/1 µL) from ZyGEM-digested male E-cells was digested with 25 
units of Benzonase® (10 µL, 2.5 units/µL) for 30 minutes at 37˚C. Next, 6 µL H2O, 3 µL 
10x Blue Buffer and 1 µL forensicGEM™ were added for a total volume of 30 µL and 
incubated at 75˚C for 15 minutes followed by 95˚C for 5 minutes. To assay for remaining 
nuclease activity, 20 µL of 9947A genomic DNA was then added and incubated at 37˚C 
for 30 minutes. 9947A is female genomic DNA from the 9947A cell line. If complete 
digestion of the starting male DNA occurs and the EA1 protease completely inactivates 
the nuclease, the resultant quant value for this sample should be consistent with the 
concentration and volume of 9947A added and should also contain no male DNA. 
As a control, the same protocol was followed with a starting sample of 10 µL of 
H2O instead of ZyGEM-extracted DNA. As a second control, the same protocol was 
followed again except the samples were not digested with Benzonase® and instead 
incubated for 30 minutes at 37˚C in 2x Benzonase® buffer and 20 µL of H2O was added 
to the sample instead of 9947A genomic DNA. All incubations were conducted in a 
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SimpliAmp thermal cycler and samples, including the stock 9947A genomic DNA, were 
quantified. 
2.4.1. ZyGEM Reactivation to Degrade Benzonase® 
In order to have a more streamlined process, an experiment was designed to 
determine if the EA1 protease could be reactivated after Benzonase® digest of E-cell 
DNA. This required that the initial lysis step would proceed to 75˚C only so as to not 
irreversibly inactivate EA1. Twenty microliters of a male E-cell sample was digested 
with ZyGEM (67 µL H2O, 10 µL 10x Blue Buffer, 3 µL forensicGEM™; total volume of 
100 µL) at 75˚C for 15 minutes and then cooled to 5˚C for 5 minutes. The samples were 
then centrifuged at 21,130 x g in a microcentrifuge for 5 minutes to mimic a differential 
protocol to pellet sperm cells (some genomic DNA from ZyGEM lysates has been shown 
to migrate to be in the pellet when centrifuged at high speeds), 80 µL of the supernatant 
was removed, 50 units of Benzonase® was added (20 µL, 2.5 units/µL) and samples were 
incubated at 37˚C for 30 minutes, 75˚C for 15 minutes, 95˚C for 5 minutes and 5˚C for 5 
minutes. Twenty microliters of 9947A was added and samples were incubated for 30 
minutes at 37˚C for 30 minutes and cooled to 5˚C for 5 minutes. The samples were 
subsequently quantified. 
To confirm that EA1 was responsible for inactivating the nuclease, a set of 
samples was heated to 95˚C for 5 minutes (inactivating EA1) after the first incubation at 
75˚C and the rest of the procedure followed as previously described. To determine if 
heating Benzonase® to 95˚C was sufficient to inactivate the nuclease, a set of samples 
with only 20 µL of Benzonase® (2.5 units/µL, 50 units total) was incubated at 37˚C for 
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30 minutes, 75˚C for 15 minutes and 95˚C for 5 minutes. Twenty microliters of 9947A 
DNA was then added and incubated at 37˚C for 30 minutes. To determine if complete E-
cell DNA degradation took place, a set of samples was quantified after digestion with 
ZyGEM and Benzonase® without the addition of 9947A DNA. To determine an 
approximate starting DNA mass, a set of E-cell samples was quantified after digesting 
with ZyGEM. 
2.5. Differential Extraction with Benzonase®: Second Protocol 
An E-/sperm cell mixture was analyzed following the direct lysis differential 
extraction protocol with the optimized Benzonase® concentration. Equal volumes of a 1:5 
E-cell dilution and a 1:100 semen dilution were combined to create a cell mixture. In a 
0.2 mL PCR tube, 40 µL of the cell mixture was extracted in 47 µL H2O, 10 µL 10x Blue 
Buffer and 3 µL forensicGEM™ (100 µL total volume) at 75˚C for 15 minutes followed 
by 5˚C for 5 minutes. The samples were centrifuged at 21,130 x g in a microcentrifuge 
for 5 minutes and 80 µL of the NSF was pipetted off and transferred to an appropriately 
labeled tube. The NSF was subsequently incubated at 95˚C for 5 minutes. Fifty units of 
Benzonase® (20 µL, 2.5 units/µL) was added to the sperm pellet; samples were vortexed 
and incubated at 37˚C for 30 minutes, 75˚C for 15 minutes, 95˚C for 5 minutes and 5˚C 
for 5 minutes. The samples were then digested according to manufacturer’s instructions 
using 38 µL H2O, 10 µL Acrosolv, 10 µL 10x Orange Buffer and 2 µL forensicGEM™ 
(100 µL total volume) at 52˚C for 5 minutes, 75˚C for 3 minutes, 95˚C for 3 minutes and 
5˚C for 5 minutes. A total of three samples from the same cell mixture were extracted 
with this protocol. 
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Equal volumes of E-cell and sperm cell dilutions (20 µL) were digested separately 
using ZyGEM and Acrosolv to determine approximate DNA contributions from each 
sample type. To confirm complete degradation of E-cell DNA, 20 µL of E-cells were 
extracted with ZyGEM, digested with Benzonase® and analyzed alongside the other 
samples. Forty microliters of the cell mixture was extracted using Acrosolv without 
Benzonase®, both with and without ZyGEM extractions and centrifugation. Three sperm 
only samples were extracted following the entire protocol and three sperm only samples 
were incubated with Benzonase® for 30 minutes at 37˚C and extracted with Acrosolv to 
determine the effects of not inactivating the nuclease. All incubations were conducted in 
a SimpliAmp thermal cycler and samples were quantified, 1 ng of DNA was amplified, 
separated by CE and EPGs were generated. 
2.6. Differential Extraction with Benzonase®: Increased Ratios of E-Cells to 
Sperm Cells 
A saliva sample from a new anonymous donor was prepared and the cells were 
resuspended in a smaller volume of PBS to make for a more concentrated E-cell sample; 
the concentrated sample was subsequently diluted 1:2 and 1:5. One to 100, 1:200 and 
1:500 semen dilutions were prepared and 100 µL of each dilution of both cell types was 
aliquoted to create 9 cell mixtures with varying ratios of E-cells to sperm cells (undiluted 
E-cells and 1:100 sperm, undiluted E-cells and 1:200 sperm, etc.). Forty microliters of 
each mixture was extracted following the previously described differential extraction 
protocol, sperm fractions were quantified, amplified with a target of 0.7 ng, separated via 
CE and analyzed as previously described. For samples with quantification values below 
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.07 ng/µL, 10 µL of the sample was amplified. Twenty microliters of each saliva and 
semen dilution were extracted with ZyGEM and Acrosolv, respectively, and quantified to 
determine approximate DNA contributions from each cell type to each mixture.  
3. Results and Discussion 
3.1. Lysis Comparison of ZyGEM and QIAamp DNA Investigator Kits 
E-cell lysis using the ZyGEM and Qiagen Buffer AL combined protocol 
described in section 2.1 of the material and methods was compared to E-cell lysis using 
ZyGEM and Qiagen standard protocols. ZyGEM lysates that were not further purified 
yielded the highest DNA mass (mean=63.9 ng/µL; n=2). Following purification using 
Qiagen QIAamp silica columns, human DNA quantification values indicated ZyGEM 
extractions and Qiagen ATL lysis resulted in similar total DNA yields (mean=40.6 for 
ZyGEM and 32.4 for Qiagen; n=2 for each extraction method; shown in Figure 4). While 
the sample size for each extraction method is low, this suggests that the front-end lysis 
efficiencies of the two methods are comparable. 
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Figure 4. Average DNA mass extracted in ng from Qiagen ATL/PK lysis purified using QIAamp silica 
columns, ZyGEM direct lysis and ZyGEM lysis purified using Qiagen QIAamp silica columns. Values 
determined using Quantifiler® Duo in a 7500 Real-Time PCR instrument (n=2 for each extraction method) 
3.2. Differential Extraction with Benzonase®: First Protocol 
The EPGs generated indicated the initial protocol described in section 2.2 failed 
in both sufficient degradation of E-cell DNA and lysis of without degradation of sperm 
DNA. The cell mixture samples that were treated with Benzonase® prior to sperm cell 
lysis resulted in a DNA profile similar to the cell mixture sample whose E-cell DNA was 
not degraded with the nuclease (Figure 5). Either the nuclease was not active or the 
concentration was not high enough to detect degradation of E-cell DNA. Additionally, a 
sperm only control that was carried through the entire protocol appeared to be degraded; 
the alleles at loci with larger amplicon sizes had much smaller peak heights compared to 
alleles at loci with smaller amplicons, a tell-tale sign of DNA degradation (Figure 6). The 
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concentration of Benzonase® tested resulted in noticeable degradation in the profiles of 
only some samples, suggesting that the concentration of Benzonase® needed to be 
optimized. Additionally, modifications to the protocol were needed in order to rapidly 
inactivate the nuclease and ensure sperm DNA would not be degraded following the 
addition of Acrosolv to release sperm DNA. 
 
 
Figure 5. Blue dye channel of EPGs generated using Identifiler Plus® from sperm fractions of mixture 
samples without Benzonase® (top) and with Benzonase® (bottom) following an initial attempt at a 
differential extraction. 
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Figure 6. Blue dye channel of EPGs from a sperm only samples digested with Benzonase® (top) and a 
sperm sample not digested with Benzonase® (bottom) amplified with Identifiler® Plus 
3.3. Benzonase® Optimization 
3.3.1. Benzonase® Concentration 
Approximately 7.5 ng of DNA was digested with 25, 2.5, 0.25 and 0 units of 
Benzonase® in a final volume of 20 µL for 30 minutes at 37˚C. All samples digested with 
25 and 250 units of Benzonase® had human and male DNA concentrations of 0 ng/µL. 
One of the two samples digested with 2.5 units of Benzonase® had no human DNA 
detected and a male DNA concentration of 0.002 ng/µL (sample 2.5A) and the other 
sample had neither human nor male DNA (sample 2.5B). As a result, the Benzonase® 
dilution that was used for subsequent experiments was 2.5 units/µL (either 10 or 20 µL 
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was added depending on the experiment and was specified in respective materials and 
methods sections for a total of either 25 or 50 units of Benzonase®). The samples that 
were digested with 0 units of Benzonase® had human DNA concentration values of 0.260 
and 0.275 ng/µL, consistent with previously determined values for the starting DNA 
sample, indicating the sequence of steps in the protocol did not result in DNA loss. 
Additionally, all internal positive control (IPC) Ct values were within the normal range. 
Quantifiler® Duo results are listed in Table 1. The concentration of Benzonase® required 
to completely digest approximately 7.5 ng of DNA was significantly greater than the 
0.005 units used for the first attempt at a differential extraction, explaining why there was 
no evidence of significant E-cell degradation in the sperm fraction EPGs. 
 
Table 1. Quantifiler® Duo results of purified DNA samples digested with 0, 2.5, 25 and 250 units of 
Benzonase®. Nuclease digestion was stopped by ZyGEM digest of the samples. The starting DNA 
concentration was also quantified and determined to have human and male DNA concentrations of .854 
ng/µL and .720 ng/µL, respectively. All concentrations listed in ng/µL 
Units of Benzonase® Sample Name 
DNA Concentration 
Human Male 
0 
0A 0.260 0.205 
0B 0.275 0.317 
2.5 
2.5A 0 0.002 
2.5B 0 0 
25 
25A 0 0 
25B 0 0 
250 
250A 0 0 
250B 0 0 
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3.3.2. Buffer Compatibility Tests 
Following the experiment outlined in section 2.3.2, various combinations of the 
buffers used for Benzonase® and ZyGEM digestions were tested. The performance of the 
Quantifiler® Duo reaction and IPC control were used as indicators that STR amplification 
would not likely be affected by the buffer components used. The DNA concentrations 
resulting from all four reagent combinations were similar, indicating the Benzonase® 
buffer and the ZyGEM reagents had no detrimental effects on the PCR-based 
quantification of DNA. The IPC Ct values for all four buffer combinations were within 
the normal range as well. The total DNA in the final samples was less than the 9 ng that 
was expected based on the previous quantification values of the purified DNA that was 
used as the starting sample; however, sample 1 was the starting DNA sample with the 
addition of only water. 
 
Table 2. Human DNA concentrations of purified DNA (10 µL, approximately 0.8 ng/µL) subjected to 
various buffer combinations encountered during the proposed protocol quantified using Quantifiler® Duo. 
Final volumes for all samples is 30 µL. 
Sample 1 2 3 4 
Purified DNA (10 µL; ~.9 
ng/µL) 
+ + + + 
Benzonase® buffer - + + - 
ZyGEM reagents - + - + 
Final DNA concentration 
(ng/µL) 
0.125 0.153 0.130 0.133 
Total DNA mass (ng) 6.25 7.67 6.50 6.65 
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3.4. ZyGEM Degradation of Benzonase® 
Following the protocol outlined in section 2.4, the presence of any residual 
nuclease activity post ZyGEM digestion was assessed by adding 9947A DNA to the post 
ZyGEM mixture and incubating at 37˚C for 30 minutes prior to quantification. The series 
of steps used and final DNA concentrations is summarized in Figure 7 below. 
  
28 
 
 
Figure 7. Flow chart of experiment to determine if ZyGEM digestion is capable of inactivating 
Benzonase® and Quantifler® Duo concentrations for each sample set. For the middle sample set, 20 µL of 
9947A genomic DNA (0.188 ng/µL) was added to samples following degradation of ZyGEM E-cell lysates 
by Benzonase® and digestion of Benzonase® with ZyGEM at a final volume of 50 µL (1:2.5 dilution of 
9947A). First and last sample sets are 9947A only and starting male DNA only controls, respectively, in 
final volumes of 50 µL with the addition of indicated components. Quantification values are summarized in 
Table 3. 
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Table 3. Quantification results of DNA degraded by Benzonase® followed by ZyGEM to inactivate 
Benzonase® and added 9947A genomic DNA. Relevant controls and expected values shown as well. All 
units are ng/µL. Flow chart of experimental steps depicted in Figure 7. 
Sample Description 
DNA Concentrations Expected DNA Concentrations 
Human Male Human Male 
DNA sample with no 
Benzonase® or 9947A 
0.190 0.151 
0.2 (based on 
previous duplicate 
quantifications) 
0.2 
9947A stock 0.188 0   
DNA digested with 
Benzonase®, then 
ZyGEM then followed 
with 9947A 
0.090 0 
0.075 (based on 
9947A value) 
0 
0.082 0 
0.075 (based on 
9947A value) 
0 
0.107 0 
0.075 (based on 
9947A value) 
0 
9947A added to 
Benzonase® inactivated 
by ZyGEM digest 
0.080 0 
0.075 (based on 
9947A value) 
0 
 
The three male DNA samples that were degraded with Benzonase®, digested with 
ZyGEM to inactivate the nuclease and followed with the addition of 20 µL of 9947A had 
human DNA concentrations of 0.090, 0.082 and 0.107 ng/µL (mean of 0.093 ng/µL; data 
shown in Table 3) and the male DNA concentrations were undetermined for all three 
samples. Based on the quantification value of the 9947A genomic DNA (0.188 ng/µL) 
and that 20 µL was added to a final volume of 50 µL (a final dilution of 1:2.5), the DNA 
concentration values of the three samples digested with Benzonase® and ZyGEM 
followed by the addition of 9947A DNA indicate that degradation of 9947A DNA and 
nuclease activity was not detected. 
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These results suggest that EA1’s proteolytic cleavage sites to Benzonase® are 
capable of irreversibly inactivating the nuclease (Figure 3). Because earlier data showed 
sperm DNA damage when the nuclease was present, sufficient degradation of the 
nuclease is necessary before sperm DNA is released by Acrosolv. Additionally, the 
control sample that was neither digested with Benzonase® nor followed with 9947A DNA 
had a human concentration of 0.190 ng/µL, consistent with the previous quantification 
values for the sample (approximately 1 ng/µL; 10 µL was added to a final volume of 50 
µL, a 1:5 dilution). This would indicate that the protocol (aside from nuclease activity) 
does not degrade DNA or inhibit downstream processes. 
3.4.1. ZyGEM Reactivation to Degrade Benzonase® 
The sequence of enzymes, samples and controls used to test inactivation of 
Benzonase® in the context of the entire process is shown in Figure 8. The starting male 
E-cell samples that were quantified after ZyGEM extraction provided DNA concentration 
values of 0.226 and 0.202 ng/µL, respectively (mean of 0.214 ng/µL). The samples which 
were digested with ZyGEM (to the 95˚C step to inactivate the EA1 protease), digested 
with Benzonase® and heated to 75˚C then 95˚C again, then had 9947A DNA added had 
human and male concentrations of 0 and IPC Ct values that were undetermined. This 
indicates that heating the nuclease to 95˚C is not sufficient for inactivation and the EA1 
protease is irreversibly inactivated at 95˚C. The samples in which the ZyGEM digest was 
stopped after the 75˚C step, however, did appear to successfully degrade the nuclease 
once the sample was heated back up to 75˚C; the two samples had an average 
quantification value of 0.067 ng/µL (.047 and .087 ng/µL, respectively) and no male 
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DNA, consistent with both the sample that had only 9947A DNA added and no starting 
DNA or nuclease (average of 0.059 ng/µL) and the quantification value of the stock 
9947A DNA (0.181 ng/µL). This data suggests that EA1 is not active at 37˚C while the 
nuclease is active and that EA1 can be reactivated once heated back up to 75˚C. 
Additionally, the two E-cell samples that were digested with Benzonase® had 
undetectable DNA concentrations and normal IPC values, indicating successful E-cell 
DNA degradation and inactivation of the nuclease. Lastly, the samples which had only 
Benzonase® and were heated to 95˚C then followed with an equal volume of 9947A DNA 
had DNA concentrations of 0 and high IPC Ct values, indicating the exogenous DNA 
used as the IPC in the quantification kit was also being degraded by the nuclease. A 
summary of the final quantification results is also provided in Figure 8. 
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Figure 8. Flow chart of experiment to determine if ZyGEM is capable of digesting Benzonase® by 
reheating the sample to 75˚C and respective Quantifiler® Duo results and final volumes for each sample set. 
20 µL 9947A genomic DNA (0.181 ng/µL) added where indicated. 
	
Male	E-Cells	 H2O	
ZyGEM	to	95˚C	
9947A	(20	µl)	
Benzonase®	
ZyGEM	to	75˚	C	
Quantification	
Centrifuge	and	remove	supernatant	
Benzonase®	
Buffer	
9947A	DNA	
Benzonase®	
0.214	ng/µl,	
0.189	ng/µL	
male	100	µl	
	
0	ng/µl;	IPC	
Ct	Undet.;	
60	µl	
	
0	ng/µl;	IPC	
normal;	40	
µl	
	
0.067	ng/µl,	
no	male;	60	
µl	
	
0.059	ng/µl,	
no	male	
DNA;	60	µl	
	
0	ng/µl;	IPC	
high;	40	µl	
	
9947A	DNA	
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3.5. Differential Extraction with Benzonase®: Second Protocol 
The differential process was modified based on the experiments described above 
and is described in section 2.5 of the materials and methods. The protocol was used on 3 
replicate samples of an E-cell/sperm cell mixture. The DNA profiles from the three 
mixture samples that underwent the full protocol indicate that sufficient degradation of 
female DNA occurred to produce a single-source male DNA profile entirely from the 
male contributor with no detectable female alleles using an analytical threshold of 30 
RFU. The two E-cell only samples that were degraded with Benzonase® had no alleles 
above the analytical threshold, further confirming sufficient degradation of the female 
DNA (Figure 9). Additionally, compared to the previous attempt at conducting a full 
differential protocol, sperm DNA from sperm only samples that followed the entire 
protocol did not show any degradation, indicating the series of steps used to keep the 
EA1 enzyme intact and reactivation of the EA1 to degrade the nuclease prior to releasing 
the sperm DNA with Acrosolv was successful (Figure 10). The sperm only samples that 
were incubated with Benzonase® only (37˚C for 30 minutes, 52˚C for 5 minutes, 75˚C for 
3 minutes and 95˚C for 3 minutes) then immediately extracted with Acrosolv showed 
significant degradation of sperm DNA in all three samples, providing further evidence 
that sufficient inactivation of the nuclease is required prior to release of sperm DNA. 
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Figure 9. EPG of E-cell sample degraded with Benzonase® with no peaks detected at an analytical 
threshold of 30. 
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Figure 10. Green dye channel of EPGs generated with Identifiler® Plus amplification of the sperm fraction 
of a mixture sample treated with Benzonase® following ZyGEM extraction (top) and a sperm sample 
extracted only with Acrosolv (bottom) indicating both absence of female DNA and no apparent degradation 
of sperm DNA. Labels indicate alleles and respective peak heights. 
 
Figure 11 shows a comparison of three profiles: the sperm fraction from a mixture 
sample that underwent the full protocol, the sperm fraction from a mixture not treated 
with Benzonase® and a sperm only sample extracted with Acrosolv at locus TH01, 
providing further support that the mixtures whose E-cell DNA was degraded by the 
nuclease yielded single-source profiles. Sperm donor alleles 7 and 9.3 are present in all 
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three samples and the female alleles, 6 and 8, are present in the mixture not treated with 
Benzonase® but are not present in the mixture sample that underwent the full protocol. 
 
Figure 11. Enhanced view of EPGs at locus TH01 from the sperm fraction of a mixture sample that 
underwent the full differential protocol without the addition of Benzonase® (top), the sperm fraction of a 
mixture sample that underwent the full differential protocol (middle) and a sperm only sample that was 
extracted with Acrosolv (bottom). Labels indicate alleles and respective peak heights. 
3.6. Differential Extraction with Benzonase®: Increased Ratios of E-Cells to 
Sperm Cells 
The modified protocol was further tested on mixtures with varying ratios of E-
cells and sperm cells (Table 4). All EPGs (except one sample which had no alleles above 
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the analytical threshold, likely due to loss of sperm pellet during the removal of the NSF) 
generated DNA profiles that were largely single source profiles of the sperm donor (i.e. 
the male contributor profile could be easily determined). Low level female alleles were 
identified in nearly every mixture but represented only partial profiles. The profile 
generated from one of three samples with the highest concentration of female DNA in the 
starting mixture is shown in Figure 12. Figures 13-16 are EPGs of one sample from each 
mixture grouped by dye channel. The samples arising from identical mixtures had similar 
profiles except for the single profile from sample 8 which had no alleles detected. Sample 
5 was not included because the male:female ratio was almost identical to sample 9 and 
the number of female alleles present in both samples was similar (Table 4). The total 
mass amplified for each sample is listed in Table 6 in the Appendix. Overall, the number 
of female alleles detected in a profile increased as the female DNA contribution relative 
to male DNA contribution increased. The female alleles that were detected were present 
predominantly in stutter position, at significantly lower peak heights than the male alleles 
and represented only partial profiles. 
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Table 4. Average number of detectable female alleles in the sperm fraction EPGs according to the 
male:female DNA ratio of each mixture. For the mixture identified with an asterisk (*), 1 of 3 samples had 
no alleles above the analytical threshold, likely due to loss of the sperm pellet when the NSF was being 
removed from the tube. Male:female DNA ratios were calculated from the individual quantification values 
determined after extracting equal volumes of each dilution with either ZyGEM or Acrosolv. Quantification 
values of these dilutions are summarized in Table 7 in the Appendix. 
Mixture Designation Mixture Components Male:Female DNA Ratio 
Average # 
Female Alleles 
1 Undiluted E-cells, 1:100 semen 1:10 2 
2 Undiluted E-cells, 1:200 semen 1:17 5.3 
3 Undiluted E-cells, 1:500 semen 1:57 5.7 
4 1:2 E-cells, 1:100 semen 1:5 1.7 
5 1:2 E-cells, 1:200 semen 1:8 1.3 
6 1:2 E-cells, 1:500 semen 1:27 3.3 
7 1:5 E-cells, 1:100 semen 1:1.5 0 
8 1:5 E-cells, 1:200 semen* 1:2.5 2 
9 1:5 E-cells, 1:500 semen 1:8.3 1 
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Figure 12 EPG generated with Identifiler® Plus amplification of the sperm fraction of a mixture with a 
starting male-to-female DNA ratio of 1:57 indicating female alleles were detected at loci D21S11 (allele 
28), D3S1358 (allele 16), TH01 (allele 6), D19S433 (allele 14) and D5S818 (allele 12). 
40 
 
Figure 13. Blue dye channels of EPGs from sperm fractions of mixture samples with various starting E-cell 
and sperm concentrations and male:female ratios. If possible, 0.7 ng of DNA was amplified with 
Identifiler® Plus; otherwise, 10 µL of a sample was amplified. Sample names in the upper left corner of 
respective EPG; sample descriptions and DNA mass amplified listed in table in Appendix. 
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Figure 14 Green dye channels of EPGs generated from sperm fractions of mixture samples with various 
starting E-cell and sperm concentrations and male:female ratios. If possible, 0.7 ng of DNA was amplified 
with Identifiler® Plus; otherwise, 10 µL of a sample was amplified. Sample names in the upper left corner 
of respective EPG; sample descriptions and DNA mass amplified listed in table in Appendix. 
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Figure 15 Yellow dye channels of EPGs generated from sperm fractions from mixture samples with 
various starting E-cell and sperm concentrations and male:female ratios. If possible, 0.7 ng of DNA was 
amplified with Identifiler® Plus; otherwise, 10 µL of a sample was amplified. Sample names in the upper 
left corner of respective EPG; sample descriptions and DNA mass amplified listed in table in Appendix. 
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Figure 16 Red dye channels of EPGs generated from sperm fractions from mixture samples with various 
starting E-cell and sperm concentrations and male:female ratios. If possible, 0.7 ng of DNA was amplified 
with Identifiler® Plus; otherwise, 10 µL of a sample was amplified. Sample names in the upper left corner 
of respective EPG; sample descriptions and DNA mass amplified listed in table in Appendix. 
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 It happens that the respective male and female profiles share 7 alleles, including 
sharing at loci with the smallest amplicon sizes (Table 5). Because smaller loci are least 
susceptible to degradation, it is likely that the average number of female alleles is greater 
than what was observed since observations can only be made where alleles are not 
shared. Because the alleles contributed by the female E-cells that were detected above the 
analytical threshold had significantly lower peak heights than the alleles from the male 
contributor, the major contributor to the sperm fraction could still be easily determined, 
and would likely meet the definition of a major contributor. 
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Table 5. Genotypes of Identifiler® Plus loci of male and female contributors to E-/sperm cell mixtures. 
Loci arranged by dye channel (cell color corresponds to dye channel) then amplicon size (smallest to 
largest) according to Identifiler® Plus generated EPGs. 
Locus 
Mixture Contributor 
Male (Sperm 
Fraction) 
Female (Non-Sperm 
Fraction) 
D8S1179 10, 13 10, 13 
D21S11 29, 30.2 28, 32.2 
D7S820 10, 11 10, 11 
CSF1PO 10, 12 12, 12 
D3S1358 15, 17 15, 16 
TH01 7, 9.3 6, 6 
D13S317 8, 11 11, 11 
D16S539 10, 12 9, 3 
D2S1338 17, 19 20, 25 
D19S433 15, 15 14, 16.2 
vWA 16, 16 14, 17 
TPOX 7, 9 8, 8 
D18S51 18, 19 12, 16 
Amelogenin X, Y X, X 
D5S818 11, 14 12, 12 
FGA 20, 21 23, 23 
 
 This protocol as reported (1) results in a male DNA fraction with little female 
DNA present, (2) requires a single centrifugation step and no DNA purifications, (3) 
takes approximately 2.5 hours to go from cell mixture to separated E-cell and sperm cell 
fractions and (4) uses a dedicated thermal cycler in the DNA extraction lab to carry out 
extractions. 
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4.  Conclusions 
The protocol developed to process sexual assault kits using direct lysis enzymes 
has been shown to produce interpretable DNA profiles from the sperm fraction of E-
cell/sperm mixtures that are almost entirely from the male contributor, even down to a 
male-to-female DNA ratio of approximately 1:57 (1 sperm cell: 28 E-cells). Additionally, 
the nuclease chosen appears to be unable to degrade sperm DNA while the DNA is still 
bound to protamine. Because EA1 has significantly fewer cut sites to P1 and P2, this 
method provides increased feasibility compared to previous selective degradation 
methods developed to process sexual assault samples. Lastly, the shortened extraction 
time coupled with foregoing sample purifications significantly reduces the time required 
to produce PCR-ready sperm fractions. 
Further optimization of the Benzonase® concentration and/or time of digest may 
be needed in order to minimize female DNA carryover in the sperm fraction, especially 
considering the ratio of female:male cells is lower than what is sometimes encountered 
when processing sexual assault samples. Additionally, the starting volume of 
forensicGEM™ may need to be increased so that enough EA1 is present after the sperm 
pellet is centrifuged and the supernatant is pipetted out to ensure there is enough enzyme 
to completely inactivate the nuclease. 
Further testing is warranted to determine if this protocol is feasible for processing 
dried or aged samples; aged sperm, and likely their respective protamine, become fragile 
as they age, adding a layer of complexity to the use of a nuclease for these samples. 
While previous studies have shown ZyGEM and Acrosolv extractions are feasible with 
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swabs and cuttings, testing this protocol with swabs rather than liquid mixtures is also 
warranted. Additionally, increased Benzonase® concentrations and times of incubation 
can be investigated to ensure greater degradation of female DNA. 
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APPENDIX 
Table 6. Quantifiler® Duo results for sperm fractions of mixtures extracted via direct lysis differential 
extraction with varying ratios of E-cells:sperm cells and the approximate DNA mass amplified using 
Identifiler® Plus. DNA concentrations are in ng/µL and DNA mass is in ng 
Mixture Components Sample Name DNA Concentration DNA Mass Amplified Human Male 
Undiluted E-cells, 1:100 semen 
1A .205 .154 0.7 
1B .227 .190 0.7 
1C .215 .206 0.7 
Undiluted E-cells, 1:200 semen 
2A .130 .097 0.7 
2B .099 .080 0.7 
2C .132 .111 0.7 
Undiluted E-cells, 1:500 semen 
3A .046 .047 0.46 
3B .037 .020 0.37 
3C .050 .038 0.50 
1:2 E-cells, 1:100 semen 
4A .223 .188 0.7 
4B .209 .244 0.7 
4C .196 .187 0.7 
1:2 E-cells, 1:200 semen 
5A .094 .100 0.7 
5B .081 .071 0.7 
5C .137 .094 0.7 
1:2 E-cells, 1:500 semen 
6A .032 .026 0.32 
6B .035 .015 0.35 
6C .025 .027 0.25 
1:5 E-cells, 1:100 semen 
7A .231 .239 0.7 
7B .303 .291 0.7 
7C .209 .189 0.7 
1:5 E-cells, 1:200 semen 
8A .001 0 0.01 
8B .070 .070 0.7 
8C .075 .054 0.7 
1:5 E-cells, 1:500 semen 
9A .016 .015 0.16 
9B .030 .015 0.30 
9C .025 .017 0.25 
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Table 7. DNA concentrations of E-cell and semen dilutions used to create E-cell/sperm mixtures with 
varying ratios and determine the ratios of each mixture. Concentrations determined using Quantifiler® Duo. 
Cell Type & Dilution 
DNA Concentration (ng/µL) 
Human Male 
Undiluted E-cells 3.976 0 
1:2 E-cells 1.920 0 
1:5 E-cells .582 0 
1:100 semen .383 .296 
1:200 semen .230 .174 
1:500 semen .070 .052 
  
50 
LIST OF JOURNAL ABBREVIATIONS 
Anal Biochem Analytical Biochemistry 
Biochem J Biochemical Journal 
Biochim Biophys Acta Biochimica et Biophysica Acta 
Biosci Rep Bioscience Reports 
Carlsberg Res Commun Carlsberg Research Communications 
Chem Biol Drug Des Chemical Biology & Drug Design 
Cell Rep Cell Reports 
Eur J Biochem European Journal of Biochemistry 
Forensic Sci Int Forensic Science International 
Forensic Sci Int Genet Forensic Science International: Genetics 
Genome Biol Genome Biology 
Genome Res Genome Research 
Hum Biol Human Biology 
Int J Food Microbiol International Journal of Food Microbiology 
Int J Legal Med International Journal of Legal Medicine 
Investig Gen Investigative Genetics 
J Bacteriol Journal of Bacteriology 
J Biol Chem Journal of Biological Chemistry 
J Cell Biol Journal of Cell Biology 
J Clin Microbiol Journal of Clinical Microbiology 
J Colloid Interface Sci Journal of Colloid and Interface Science 
51 
J Forensic Sci Journal of Forensic Sciences 
Mol Hum Reprod Molecular Human Reproduction  
52 
BIBLIOGRAPHY 
1.  Gill P, Jeffreys AJ, Werrett DJ.  Forensic application of DNA “fingerprints.”  
Nature 1985;318(12):577–9.  
2.  Hilz H, Wiegers U, Adamietz P.  Stimulation of Proteinase K Action by 
Denaturing Agents: Application to the Isolation of Nucleic Acids and the 
Degradation of “Masked” Proteins.  Eur J Biochem 1975;56(1):103–8.  
3.  Rossen L, Nørskov P, Holmstrøm K, Rasmussen OF.  Inhibition of PCR by 
components of food samples, microbial diagnostic assays and DNA-extraction 
solutions.  Int J Food Microbiol 1992;17(1):37–45.  
4.  Goldenberger D, Perschil I, Ritzler M, Altwegg M.  A simple “universal” DNA 
extraction procedure using SDS and proteinase K is compatible with direct PCR 
amplification.  Genome Res 1995;4(6):368–70.  
5.  Kirby KS.  A new method for the isolation of deoxyribonucleic acids: evidence on 
the nature of bonds between deoxyribonucleic acid and protein.  Biochem J 
1957;66(3):495–504.  
6.  Marko MA, Chipperfield R, Birnboim HC.  A procedure for the large-scale 
isolation of highly purified plasmid DNA using alkaline extraction and binding to 
glass powder.  Anal Biochem 1982;121(2):382–7.  
7.  Boom R, Sol C, Salimans MMM, Jansen CL, Wertheim-van Dillen P, van der 
Noordaa J.  Rapid and Simple Method for Purification of Nucleic Acids.  J Clin 
Microbiol 1990;28(3):495–503.  
8.  Melzak KA, Sherwood CS, Turner RFB, Haynes CA.  Driving Forces for DNA 
53 
Adsorption to Silica in Perchlorate Solutions.  J Colloid Interface Sci 
1996;181(2):635–44.  
9.  Katevatis C, Fan A, Klapperich CM.  Low concentration DNA extraction and 
recovery using a silica solid phase.  PLoS One 2017;12(5):e0176848.  
10.  Montpetit SA, Fitch IT, O’Donnell PT.  A simple automated instrument for DNA 
extraction in forensic casework.  J Forensic Sci 2005;50(3):555–63.  
11.  Kemp BM, Winters M, Monroe C, Barta JL.  How much DNA is lost? Measuring 
DNA loss of short-tandem-repeat length fragments targeted by the PowerPlex 16® 
system using the Qiagen MinElute Purification Kit.  Hum Biol 2014;86(4):313–29.  
12.  Opel KL, Chung D, McCord BR.  A study of PCR inhibition mechanisms using 
real time PCR.  J Forensic Sci 2010;55(1):25–33.  
13.  Walsh PS, Metzger DA, Higuchi R.  Chelex 100 as a medium for simple extraction 
of DNA for PCR-based typing from forensic material.  Biotechniques 
2013;54(3):506–13.  
14.  Vuichard S, Borer U, Bottinelli M, Cossu C, Malik N, Meier V, et al.  Differential 
DNA extraction of challenging simulated sexual-assault samples: a Swiss 
collaborative study.  Investig Genet 2011;2(1):11.  
15.  Klein SB, Buoncristiani MR.  Evaluating the efficacy of DNA differential 
extraction methods for sexual assault evidence.  Forensic Sci Int Genet 
2017;29:109–17.  
16.  Hennekens CM, Cooper ES, Cotton RW, Grgicak CM.  The Effects of Differential 
Extraction Conditions on the Premature Lysis of Spermatozoa.  J Forensic Sci 
54 
2013;58(3):744–52.  
17.  Doyen CM, Moshkin YM, Chalkley GE, Bezstarosti K, Demmers JAA, Rathke C, 
et al.  Subunits of the Histone Chaperone CAF1 Also Mediate Assembly of 
Protamine-Based Chromatin.  Cell Rep 2013;4:59–65.  
18.  Wykes SM, Krawetz SA.  The structural organization of sperm chromatin.  J Biol 
Chem 2003;278(32):29471–7.  
19.  Balhorn R.  The protamine family of sperm nuclear proteins.  Genome Biol 
2007;8(9):227.  
20.  McKay DJ, Renaux BS, Dixon GH.  The amino acid sequence of human sperm 
protamine P1.  Biosci Rep 1985;391:383–91.  
21.  McKay DJ, Renaux BS, Dixon GH.  Human sperm protamines Amino-acid 
sequences of two forms of protamine P2.  Eur J Biochem 1986;156:5–8.  
22.  Castillo J, Simon L, de Mateo S, Lewis S, Oliva R, Mateo S De.  Protamine/DNA 
Ratios and DNA Damage in Native and Density Gradient Centrifugated Sperm 
from Infertile Patients.  J Androl 2010;32(3):324–32.  
23.  Balhorn R.  A Model for the Structure of Chromatin in Mammalian Sperm.  J Cell 
Biol 1982;93(May):298–305.  
24.  Ward WS.  Function of sperm chromatin structural elements in fertilization and 
development.  Mol Hum Reprod 2010;16(1):30–6.  
25.  Björndahl L, Kvist U.  Human sperm chromatin stabilization: A proposed model 
including zinc bridges.  Mol Hum Reprod 2009;16(1):23–9.  
26.  Balhorn R, Corzett M, Mazrimas J, Watkins B.  Identification of bull protamine 
55 
disulfides.  Biochemistry 1991;30(1):175–81.  
27.  Garvin AM, Bottinelli M, Gola M, Conti A, Soldati G.  DNA preparation from 
sexual assault cases by selective degradation of contaminating DNA from the 
victim.  J Forensic Sci 2009;54(6):1297–303.  
28.  Wong HG, Mihalovich JS, Sensabaugh G.  Automating the Differential Digestion 
Method in the Analysis of Sexual Assault Cases using Selective Degradation. U.S. 
Department of Justice Report.  2013;  
29.  Bergquist P, Morgan H, Saul D.  Selected Enzymes from Extreme Thermophiles 
with Applications in Biotechnology.  Curr Biotechnol 2014;3(1):45–59.  
30.  Adekoya OA, Sylte I.  The thermolysin family (M4) of enzymes: Therapeutic and 
biotechnological potential.  Chem Biol Drug Des 2009;73(1):7–16.  
31.  Saul DJ, Williams LC, Toogood HS, Bergquist PL, Daniel RM.  Sequence of the 
gene encoding a highly thermostable neutral proteinase from Bacillus sp. strain 
EA1: expression in Escherichia coli and characterisation.  Biochim Biophys Acta 
1996;1308:74–80.  
32.  Moss D, Harbison SA, Saul DJ.  An easily automated, closed-tube forensic DNA 
extraction procedure using a thermostable proteinase.  Int J Legal Med 
2003;117(6):340–9.  
33.  Montville RB.  Optimization of enzymatic lysis of epithelial cells for application 
to differential extraction of forensic sexual assault samples (Master’s thesis).  
2016; 
34.  Quinlivan EP, Gregory JF.  DNA digestion to deoxyribonucleoside: A simplified 
56 
one-step procedure.  Anal Biochem 2008;373(2):383–5.  
35.  Eaves GN, Jefferies CD.  Isolation and properties of an exocellular nuclease of 
Serratia marcescens.  J Bacteriol 1963;85(October):273–8.  
36.  Biedermann K, Jepsen PK, Riise E, Svendsen I.  Purification and characterization 
of a Serratia marcescens nuclease produced by Escherichia coli.  Carlsberg Res 
Commun 1989;54(1):17–27.  
37.  Grgicak CM, Urban ZM, Cotton RW.  Investigation of reproducibility and error 
associated with qPCR methods using Quantifiler® Duo DNA quantification kit.  J 
Forensic Sci 2010;55(5):1331–9.  
38.  QIAGEN.  QIAamp DNA Investigator Handbook.  Hilden, Germany: 2012;  
 
  
57 
CURRICULUM VITAE  
